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Abstract
Background: The consumption of n-3 polyunsaturated fatty acids (PUFAs) is important to human health, especially
in cases of cardiovascular disease. Although beneficial effects of n-3 PUFAs have been observed in a number
of studies, the mechanisms involved in these effects have yet to be discovered.
Methods: We generated hfat-1 transgenic pigs with traditional somatic cell nuclear transfer (SCNT) technology. The
fatty acid composition in ear tissue of pigs were detected with gas chromatography. The cholesterol, triglycerides
(TAG) and inflammation mediators in circulation were investigated.
Results: The hfat-1 transgenic pigs were developed which accumulate high levels of n-3 PUFAs than wild-types pigs.
Gas chromatography results demonstrated that the total n-3 PUFAs in the ear tissues of the transgenic founders were
2-fold higher than the wild-type pigs. A lipid analysis demonstrated that the levels of TAG in the transgenic pigs were
decreased significantly. The basal levels of the inflammation mediators tumor necrosis factor-α (TNF-α), monocyte
chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) in transgenic pigs were inhibited markedly compared with
the wild-type pigs.
Conclusions: These results suggest that n-3 PUFAs accumulation in vivo may have beneficial effects on vascular and
hfat-1 transgenic pigs may be a useful tool for investigating the involved mechanisms.
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Background
N-3 polyunsaturated fatty acids (PUFAs) are important
dietary fatty acids, including alpha-linolenic acid (ALA),
eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA). ALA is enriched in seed oil and can be obtained
directly through diets [1]. EPA and DHA can be con-
verted from ALA through desaturation-chain elongation
pathway in mammals [2, 3]. Although young women has
greater conversion capacity of ALA to DHA than men,
the synthesis efficiency is still limited [4–8]. Thus, the
primary source of this fatty acids for humans is dietary
supplementation.
However, fat-1 gene in caenorhabditis elegans encodes
an n-3 fatty acids desaturase which are able to convert
n-6 to n-3 fatty acids by adding a double bond into n-6
fatty acids at the n-3 hydrocarbon position [9, 10].
Researchers developed transgenic mice, pigs and cows
carrying the fat-1 gene previously and observed
higher n-3 PUFAs accumulation in tissues [11–14].
A number of observational studies, clinical trials, and
in vitro studies have demonstrated that the consumption
of n-3 PUFAs is beneficial in the management of cardio-
vascular disease, including atherosclerosis, severe ar-
rhythmias, and thrombosis, and decrease the incidence
of cardiac arrest and sudden death [15–19]. Moreover,
the American Heart Association (AHA) recommends
that an intake of approximately 500 mg/day of n-3
PUFAs be used to prevent cardiovascular disease (CVD)
and that patients with CVD should have an intake of
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2–4 g/day [20–22]. In animals, accumulation of n-3
PUFAs in fat-1 transgenic mice decreased cholesterol
level and body weight [23], attenuated vascular inflamma-
tion which represented by CD68 and neointimal hyperpla-
sia [24], protected against global ischemia injury [25].
Moreover, decreased ratio of n-6/n-3 in apoE-/-/fat-1 mice
reduced aortic lesion area significantly than that of apoE-/-
littermates [26].
Although rodents have been widely used in medical
research as disease models, some of information that
come from rodents still can not be replicated and has
failed to translate into clinical practice. The pig has a
heart size similar to that of humans, has a similar coron-
ary circulation and can develop spontaneous atheroscler-
otic lesions [27–29]. Thus, to mimic the role of n-3
PUFAs in humans, we developed hfat-1 transgenic pigs
and investigate the changes in cholesterol, TAG, and in-
flammation caused by the metabolism of n-3 PUFAs.
Methods
Generation of transgenic pigs
The hfat-1 expression plasmid with CAG promoter was
donated by Dr. Dai (Nanjing Medical University, Jiangsu,
China). The fat-1 gene is from C. elegans (GenBank:
NM_001028389) and was optimized for mammal ex-
pression. The plasmid (Fig. 1) was linearized and trans-
fected into primary fetal fibroblasts that were isolated
from a Song-liao black pig using Fugene HD (Roche, Ba-
sel, Switzerland). After 24 h of transfection, the cells
were split 1:36 and cultured in selection medium con-
taining 500 μg/ml G418 antibiotic (Merck, Shanghai,
China). After 10 days of selection, the surviving cell col-
onies were propagated in 24-well plates with 200 μg/
ml G418 antibiotic for another 4 days. G418 resistant
clones were analyzed with PCR assays (Tiangen, Beijing,
China) using the following primers: hfat-1 identi forward
(GGA CCT GGT GAA GAG CAT CCG) and hfat-1
identi reverse (GCC GTC GCA GAA GCC AAA C) lo-
cated in the hfat-1 gene and neo identi forward (ATG
ATT GAA CAA GAT GGA TTG CAC GC) and neo
identi reverse (TCA GAA GAA CTC GTC AAG AAA
GGC GAT AG) located in the neomycin gene. The PCR
assays were conducted using 30 cycles of denaturation at
94 °C for 30 s, annealing at 55 and 50 °C for 30 s, and
extension at 72 °C for 90 s. The PCR products were ana-
lyzed by electrophoresis and sequencing to confirm the
integrity of the hfat-1 gene within the pig genome in the
G418 resistant clones. The five identified positive col-
onies were selected as donor cells to perform somatic
cell nuclear transfer (SCNT) and embryo transfer as pre-
viously described [30]. The pigs housed in a 18–20 °C en-
vironment in winter with free access to water and were
fed three times per day (morning, 6:00; noon, 13:00;
evening, 17:30) with a diet containing crude protein 15
% and crude fat 4 %. All the animal experiments and
maintenance protocols were in accordance with the
Guide for the Care and Use of Laboratory Animals and
were approved by Jilin University.
Genotype and tissue fatty acid analysis of the founders
Genomic DNA from the cloned piglets was extracted
from the tails and subjected to PCR analysis to confirm
the insertion of the hfat-1 gene using the hfat-1 identi
forward and reverse primers. The PCR products were
analyzed by electrophoresis and sequencing. The fatty
acid composition in the ears which selected according to
the previous research of the transgenic founders was an-
alyzed using gas chromatography–mass spectrometry
(GC–MS) (6890 N, Agilent, USA) method as described
in other reports [13, 31, 32]. The initial temperature of
the program was 160 °C for 2 min, then increased at a
rate of 1 °C/min to 210 °C for 50 min. The fatty acid
concentration is presented as a percentage of the total
fat in the ears. Each value represents the mean ± stand-
ard deviation. Each sample measurement was performed
three times.
Quantitative real-time PCR
Blood was collected from pigs using anticoagulant EDTA
tubes, and peripheral blood mononuclear cells (PBMCs)
were isolated from the whole blood with Histopaque-
1077(Sigma Inc., USA) according to the manufacturer’s
instructions. Briefly, add 5 ml Histopaque-1077 into
50 ml tube, carefully add 5 ml blood onto Histopaque-
1077, centrifuge at 400 × g for 30 min, carefully transfer
the opaque interface which containing PBMCs into a
new tube. Total RNA was isolated from the PBMCs
(five transgenic pigs and three wild-type pigs) using
the TRIzol-A+ reagent (Tiangen, Beijing, China) accord-
ing to the manufacturer’s instructions. First-strand
cDNAs were synthesized from 1 μg of total RNA
using a BioRT cDNA first stand synthesis kit (Bioer,
Fig. 1 The expression cassette, mainly including the pCAG promoter, humanized fat-1 gene, and a neomycin selection cassette
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Hangzhou, China), and the samples were analyzed
with a Bioeasy SYBR green I real-time PCR kit (Bioer,
Hangzhou, China). The detection of inflammation me-
diators were performed using the following primers:
pMCP-1 forward (TCACCAGCAGCAAGTGTCCT) and
pMCP-1 reverse (ATGTGCCCAAGTCTCCGTTT); pIL-
6 forward (TGGGTTCAATCAGGAGAC) and pIL-6 re-
verse (CTGACCAGAGGAGGGAAT); pTNF-α forward
(CGCATCGCCGTCTCCTACCA) and pTNF-α reverse
(TGCCCAGATTCAGCAAAGTCCA). The gene ex-
pression was normalized against the internal control
(β-actin).
Plasma lipid and lipoprotein analysis
After 16 h of food deprivation, 5 ml of blood was ob-
tained from precaval vein of each pig. Centrifuge at
1000 × g for 10 min to obtain plasma. The TAG, total
cholesterol (TC), HDL-C and LDL-C levels in each sample
were determined by corresponding kit (ERKN, Zhejiang,
China) and analyzed using Beckman coulter UniCel DxC
800 Synchron (Beckman coulter, USA) by No. 208
Hospital of the People’s Liberation Army.
Statistical analysis
Data in Figs. 3 and 4 are expressed as the mean ± SEM.
Comparisons were performed using an unpaired two-
tailed Student’s t-test unless otherwise specified. Data
were analyzed using GraphPad Prism6. P < 0.05 was con-
sidered to be statistically significant.
Results
Generation of hfat-1 transgenic pigs
Unlike the development of transgenic mice which use
embryonic stem cells (ES) for preselection of gene in-
sertion [33], primary embryonic pig fibroblasts were
employed for transfection with a linearized hfat-1 ex-
pression plasmid. The screening for positive cells was
performed in G418-containing culture medium for
10 days; 50 G418 -resistant clones were picked and
analyzed via PCR for the integration of hfat-1 cDNA.
Thirty clones exhibited both the expected 458 bp
band of hfat-1 and the 790 bp band of the neomycin
sequence (data not shown); 5 of these clones were se-
lected for presentation in this paper and for individu-
ally performing somatic SCNT in the following step
(Fig. 2a and b).
On average, 248 reconstructed embryos from each
positive clone were transferred into each naturally
cycling gilt, and totally five recipients. At days 25–28,
2 recipients (40 %) became pregnant, as determined
by ultrasound scanning. One of these aborted at
29 days, and one pregnancy went to term (20 %). Five
piglets were born by natural delivery. The cloning ef-
ficiency was 0.4 % (No. of piglets/No. of embryos
transferred). The genomic PCR assay was performed
using DNA extracted from the tail tissue, and the
Fig. 2 Identification of G418-resistant clones and hfat-1 transgenic pigs. Analyse of the hfat-1 gene and neomycin gene integration into the pig
genome in the G418-resistant clones were performed using a PCR assay with the primer pairs of hfat-1 identi (458 bp) (a) and neo identi (790 bp) (b).
a 1–5, five G418-resistant clones, on which SCNT was individually performed in the following procedure. 6, hfat-1 plasmid as a positive control. 7–8,
negative controls. b 1, hfat-1 plasmid as a positive control. 2–3, negative controls. 4–8, five G418-resistant clones. The hfat-1 gene integration into the
pig genome and transcription in the transgenic pigs were analyzed using PCR (c) and RT-PCR (d), respectively, with the hfat-1 identi primer
pair (458 bp). c 1–5, five hfat-1 transgenic pigs. 6, hfat-1 plasmid as a positive control. 7–8, two wild-type pigs. d 1–5, five hfat-1 transgenic
pigs. 6–7, two wild-type pigs
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results show that all five piglets were positive for the
hfat-1 transgene (Fig. 2c).
Accumulation of n-3 PUFAs in the transgenic pigs
To examine whether hfat-1 was transcribed in the trans-
genic pigs, reverse transcription PCR was performed
using cDNA obtained from the tail. The results show
that hfat-1 was transcribed in all five of hfat-1 positive
transgenic pigs (Fig. 2d). To investigate whether the
transfected hfat-1 gene was functional in the transgenic
pigs, gas chromatography was performed to determine
the composition of the PUFAs. The fatty acid profiles in
Table 1 were derived from the ear tissues of five trans-
genic pigs and three wild-type pigs. The total n-3 PUFAs
in the ear tissues of the transgenic founders were 2-fold
higher than those of the wild-type pigs. However, the
n-6 PUFAs of the transgenic founders were not sig-
nificantly altered, and the ratio of n-6/n-3 fatty acids
was reduced 2-fold in the transgenic founders com-
pared with the wild-type pigs.
Lipid analysis of the hfat-1 transgenic pigs
There were no difference of body weight between wild-
type and transgenic pigs (Fig. 3a). To examine whether
an abundance of n-3 PUFAs is beneficial to the vascula-
ture, the cholesterol and TAG concentrations in the
blood of one-year-old transgenic and wild-type pigs were
measured. The results demonstrated that TC was not
different between transgenic and wild-type pigs in fast-
ing states (Fig. 3b). HDL-C and LDL-C levels were also
not significantly altered under the same conditions
(Fig. 3c and d). However, the level of TAG in hfat-1
transgenic pigs was decreased significantly compared
with the wild-type pigs (Fig. 3e).
Table 1 Statistical analyses were performed using an unpaired
two-tailed Student’s t-test
Fatty acid in ears Transgenic piglets (n = 5) Wild-type piglets (n = 3)
18:3 n-3 (%) 2.25 ± 0.15 1.12 ± 0.09
20:5 n-3 (%) (EPA) 2.71 ± 0.72 1.09 ± 0.12
22:5 n-3 (%) 1.23 ± 0.21 0.51 ± 0.06
22:6 n-3 (%) (DHA) 1.15 ± 0.17 0.38 ± 0.08
18:2 n-6 (%) 3.28 ± 0.25 5.72 ± 0.64
20:4 n-6 (%) 5.78 ± 0.57 5.65 ± 0.39
22:5 n-6 (%) 1.19 ± 0.22 2.22 ± 0.16
Total n-3 FA (%)a 7.34 ± 0.76 3.10 ± 0.06
Total n-6 FA (%) 10.25 ± 2.28 13.59 ± 0.24
n-6/n-3 ratioa 1.81 ± 0.41 4.38 ± 0.64
aP < 0.01 Table 1 n-3 and n-6 fatty acids concentration and n-6/n-3 ratios in
ear samples from hfat-1 transgenic pigs and wild-type pigs
Fig. 3 The body weight and plasma characters. a The body weight of wild-type and hfat-1 transgenic pigs at 18 month. Plasma was isolated from the
blood of the transgenic and wild-type pigs after 16 h of food deprivation and assayed for TC (b), HDL-C (c), LDL-C (d), and TG (e). ***, p < 0.001
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Inflammatory factors analysis of the hfat-1 transgenic pigs
Because cardiovascular disease correlates with chronic
inflammation, the transcription and concentration of in-
flammation genes were measured with a real-time PCR
assay using PBMCs cDNA and with Elisa using plasma
of the transgenic and wild-type pigs. The result shows
that MCP-1, IL-6 and TNF-α mRNA levels were re-
duced obviously in the transgenic pigs compared with
the wild-type pigs (Fig. 4a, b and c). In accordance
with the transcription level, the concentrations of
MCP-1, IL-6 and TNF-α were decreased significantly
as well. These results indicate that an abundance of
n-3 PUFAs is beneficial for maintaining a lower level
of inflammation in the body, which is consistent with
previous research [24, 26, 34].
Discussion
N-3 PUFAs are important for human health. Moreover,
meat products usually have less n-3 and more n-6
PUFAs. The imbalance of n-6/n-3 intake contribute to
the development of CVD [18, 35]. In this study, we in-
troduced the n-3 fatty acid desaturase encoding gene
fat-1 from C .elegans into the pig using SCNT technol-
ogy, and the gene was successfully expressed in the
transgenic pigs. The cholesterol, TAG and inflammatory
cytokines of hfat-1 transgenic pigs were determined.
The hfat-1 transgenic pigs in our study were cloned
from one G418 resistant clone for more stable gene ex-
pression and accumulation of fatty acids. The concentra-
tions of total n-3 PUFAs in the ear tissues of our
transgenic founders were two-fold higher than in the
wild-type pigs, but the n-6 PUFAs were less altered.
Additionally, the EPA and DHA levels showed a 2-fold
and 3-fold increase in the transgenic founders, respect-
ively. Consequently, the ratio of n-6/n-3 fatty acids was
decreased two-fold in the transgenic founders compared
with wild-type pigs. In a previous study, Saeki et al. got
20 % more linoleic acid (omega-6 PUFA) in adipose tis-
sue in △12 fatty acid desaturase gene transgenic pigs
[36]. Lai et al. reported that the levels of n-3 PUFAs in
the tail tissues of transgenic pigs were three-fold higher
than those in wild-type pigs, and the ratio of n-6/n-3
fatty acids was reduced five-fold in the transgenic pigs
[14]; Zhou et al. reported that the level of n-3 PUFAs in
the muscle tissues of cbr-fat-1 transgenic pigs was six-
fold higher than that of the wild-type pigs and the ratio
of n-6/n-3 fatty acids was reduced 10.5 fold in the trans-
genic founders [11]. However, the accumulation of n-3
Fig. 4 The levels of proinflammatory cytokines in hfat-1 transgenic pigs. Total RNA was isolated from the blood monoyte of transgenic
and wild-type pigs and qRT-PCR was performed. a-c MCP-1, IL-6 and TNF-α mRNA level in transgenic and wild-type pigs. Plasma was isolated from
the blood of the transgenic and wild-type pigs and MCP-1, IL-6 and TNF-α concentration were analysed by Elisa. d-f MCP-1, IL-6 and TNF-α concentra-
tion in transgenic and wild-type pigs. All data are presented as the mean ± SEM (five transgenic pigs and three wild-type pigs) *, P < 0.01. **, P < 0.001
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PUFAs is not as high and the ratio of n-6/n-3 PUFAs is
not altered as much in our results as in previous reports.
In fat-1 transgenic mice, decreased HDL-C, LDL-C, TC
and TAG were observed, but the body weight is not uni-
form [23, 37]. In the hfat-1 transgenic pig, there was no
difference observed in body weight compared to wild-type
pigs. A high level of TAG is supposed to be an independ-
ent risk factor of coronary heart disease (CHD) according
to AHA reports [20, 38]. As pigs, the basal TAG levels in
Song-liao black is higher compared with other miniature
pigs (data not shown). In the hfat-1 transgenic pigs, the
accumulation of n-3 PUFAs lowered the TAG levels sig-
nificantly in circulation in a fasting states compared with
the levels in the wild-type pigs. In addition, plasma TC
and HDL-C were not changed in the transgenic pigs.
Plasma LDL-C was not statistically decreased. Therefore,
the lowered TAG levels might exert some protective ef-
fects in the hfat-1 transgenic pig.
Chronic inflammation plays an important role in the
progression of cardiovascular disease. A number of stud-
ies have reported that EPA and DHA or fish oil inhibit
endotoxin-induced IL-6, TNF-α and IL-1∙production in
vitro and in vivo [39–42]. In the hfat-1 transgenic pigs,
the basal mRNA levels of the inflammation mediators
IL-6, TNF-α and MCP-1 were inhibited compared with
those of the wild-type pigs. In accordance with the
mRNA level, the concentrations of MCP-1, IL-6 and
TNF-α were decreased significantly as well. Therefore,
the anti-inflammatory effects of n-3 PUFAs may contrib-
ute to the lower inflammation levels in mammals.
Although the accumulation of n-3 PUFAs in our
transgenic pigs was not as high as previous reports,
the TAG and inflammatory factor levels were de-
creased indeed under similar total n-3 plus n-6
PUFAs levels. The results illustrated that moderate al-
teration of n-6/n-3 PUFAs ratio is enough to affect
metabolism in mammals.
Conclusions
We obtained hfat-1 transgenic pigs that accumulate
higher levels of n-3 PUFAs than do wild-type pigs.
The n-3 PUFAs in the ear tissues of the transgenic
founders were 2-fold higher than those of the wild-
type pigs. TAG levels in the hfat-1 transgenic pigs
were decreased significantly, whereas TC, HDL-C and
LDL-C were not statistically different. However, the
levels of the inflammatory mediators IL-6, TNF-α and
MCP-1 were decreased significantly as well. There-
fore, n-3 PUFAs supplementation in human daily life
may have protective effects on vascular.
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